1-3 of 3
Rupal Soder
Close
Sort by
Journal Articles

Relapse Prophylaxis Post-Haploidentical Bone Marrow Transplantation and Cyclophosphamide (Haplo/Cy) By Infusion of Donor-Derived Expanded/Activated Gd T Cells: A Phase I Trial

Joseph P. McGuirk, Sunil H Abhyankar, Trishna Goswami, Rupal Soder, Mariska ter Haak, Tyce Bruns, Samantha Langford Youngblood, Lawrence S. Lamb, Jr.
Journal: Blood
Blood (2022) 140 (Supplement 1): 7464–7465.
https://doi.org/10.1182/blood-2022-169819
Published: 2022
Journal Articles

First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide

Lawrence S. Lamb, Jr., PhD, Melissa Jo Beelen, Mjbeelen@incysus.com, Samantha Langford Youngblood, BS, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-142876
Published: 2020
Journal Articles

CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles

Neil Dunavin, MD, Meizhang Li, PhD, Safinur Atay, PhD, Jim Mitchell, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO, Andrew K Godwin, PhD, Buddhadeb Dawn, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5095.
https://doi.org/10.1182/blood-2018-99-116921
Published: 2018